Prostaglandin F2alpha for Ox: Reproductive Uses, Dosing & Safety

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Prostaglandin F2alpha, often shortened to PGF2alpha, is a reproductive hormone used in cattle medicine to cause luteolysis, or regression of the corpus luteum. In practical terms, that means it lowers progesterone support from an active corpus luteum so a cycling cow can return to estrus. The two products most commonly used in US cattle practice are dinoprost tromethamine and cloprostenol, a synthetic prostaglandin analogue.

Your vet may use this medication as a stand-alone injection or as one step in a larger breeding program. In cycling cattle with a functional corpus luteum, labeled doses can bring cows or heifers into estrus in about 2 to 6 days. That makes PGF2alpha useful for herd reproductive planning, timed breeding programs, and selected uterine conditions tied to persistent luteal function.

This is not a routine medication to give without a clear reproductive goal. It is a prescription drug in food animals, and timing matters. If the animal is not cycling, does not have a responsive corpus luteum, or is pregnant when pregnancy should be maintained, the result may be poor response or unintended pregnancy loss. Your vet will match the product, timing, and handling plan to the animal's stage of cycle, breeding status, and food-animal recordkeeping needs.

In cattle, prostaglandin F2alpha is used most often for estrus synchronization and management of silent or unobserved estrus in animals that are cycling normally but still have a functional corpus luteum. It is also a core part of many timed artificial insemination programs, including protocols that combine GnRH and PGF2alpha. These programs help coordinate breeding when heat detection is difficult or labor is limited.

Your vet may also use PGF2alpha for several reproductive disorders linked to persistent luteal tissue. Common labeled uses include pyometra or chronic endometritis, luteal cysts, and mummified fetus. In these cases, the drug helps remove progesterone support so the uterus can clear contents and the animal can return to a more normal cycle.

Some products are also labeled for termination of unwanted pregnancy in certain classes of cattle and at specific gestational windows. That decision needs careful veterinary oversight because response depends on stage of gestation, product label, and the animal's production class. PGF2alpha is not a treatment for every postpartum discharge problem. For example, it has not been shown to reliably hasten expulsion of retained fetal membranes, so your vet may recommend a different plan if that is the main concern.

Dosing depends on the exact product your vet chooses. In cattle, standard labeled luteolytic doses are dinoprost 25 mg IM or cloprostenol 500 mcg IM per animal. Merck Veterinary Manual notes that these doses, given to cows with a functional corpus luteum starting about 5 days after ovulation, typically result in estrus about 2 to 6 days later. Some synchronization programs use two PGF2alpha injections 12 to 14 days apart, while others combine PGF2alpha with GnRH and sometimes a progesterone device.

Product labels matter. ESTRUMATE is labeled at 2 mL IM per cow, which delivers 500 mcg cloprostenol. LUTALYSE products are labeled to deliver 25 mg dinoprost per cow. The same drug may be used for silent estrus, pyometra, luteal cysts, mummified fetus, or pregnancy termination, but the timing, follow-up breeding plan, and recheck schedule can differ by indication.

This medication should be given only under your vet's direction. In food animals, route, timing, and records are important. Your vet may confirm cycling status by history, rectal palpation, ultrasound, or herd protocol before treatment. If the animal is anestrous, too early in the cycle, or not a good candidate for synchronization, repeating the same dose without a plan may not help.

For labeled cattle uses, dinoprost and cloprostenol products commonly used in the US have no milk discard and no preslaughter withdrawal period when used according to label directions. Extra-label use changes the risk picture, so withdrawal guidance must come from your vet.

Most cattle tolerate labeled doses well, but mild short-lived reactions can occur. Reported effects include uneasiness, slight frothing or salivation, milk let-down, and a transient increase in heart rate. Injection-site problems are uncommon with proper technique, but severe localized clostridial post-injection infections have been reported with prostaglandin products, and rare cases have been fatal.

The biggest practical risk is often not the cow's reaction but the reproductive effect. If PGF2alpha is given to a pregnant animal when pregnancy should be maintained, it can cause abortion or pregnancy loss. That is why your vet will want accurate breeding dates, pregnancy status, and the reason for treatment before giving the drug.

Human safety matters too. Cloprostenol is readily absorbed through the skin and can cause abortion and/or bronchospasm in people. Women of childbearing age, pregnant people, asthmatics, and anyone with respiratory disease should use extreme caution and avoid direct exposure. If there is accidental skin contact, wash immediately with soap and water. If accidental self-injection occurs, seek medical care right away and bring the product label.

Prostaglandin F2alpha is often used with other reproductive drugs rather than avoided because of them. In cattle practice, your vet may pair PGF2alpha with GnRH products in timed-AI protocols such as Ovsynch, or use it alongside a progesterone-releasing intravaginal device as part of a synchronization plan. These combinations are intentional and protocol-dependent.

The main concern is not a long list of classic drug interactions, but whether another hormone or management step changes the expected reproductive response. For example, giving PGF2alpha to an animal without a functional corpus luteum may produce little or no effect. Likewise, using it in a pregnant animal, or in the wrong stage of cycle, can create outcomes your vet is trying to avoid.

Tell your vet about any recent GnRH, progesterone device, steroid hormone, or reproductive treatment the animal has received, along with breeding dates and pregnancy checks. Also mention any history of severe injection-site reactions or herd issues after hormone protocols. In food animals, your vet also needs a complete treatment record so withdrawal guidance stays accurate if any use falls outside the label.